Discontinued — last reported Q1 '26
UnitedHealth Group Optum Rx — Earnings before income taxes decreased by 58.7% to $1.19B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 9.6%, from $1.32B to $1.19B. Over 4 years (FY 2021 to FY 2025), Optum Rx — Earnings before income taxes shows an upward trend with a 14.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
A strong indicator of the segment's overall financial health and its contribution to the parent company's pre-tax earnings.
The pre-tax profit of the pharmacy benefit management segment, accounting for operating income, interest, and other non-...
Standard pre-tax segment earnings metric used for cross-company performance benchmarking.
unh_segment_optum_rx_earnings_before_income_taxes| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $993.00M | $1.01B | $1.24B | $939.00M | $1.04B | $1.08B | $1.37B | $1.06B | $1.21B | $1.26B | $1.59B | $1.15B | $1.41B | $1.54B | $1.74B | $1.32B | $1.44B | $1.55B | $2.89B | $1.19B |
| QoQ Change | — | +1.9% | +22.5% | -24.3% | +11.2% | +3.5% | +26.9% | -22.7% | +13.8% | +4.2% | +26.7% | -28.0% | +22.6% | +9.8% | +12.6% | -24.2% | +9.3% | +7.5% | +86.2% | -58.7% |
| YoY Change | — | — | — | — | +5.1% | +6.8% | +10.6% | +12.9% | +15.5% | +16.3% | +16.0% | +8.2% | +16.6% | +22.8% | +9.2% | +14.9% | +2.5% | +0.3% | +65.9% | -9.6% |